# LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)

> **NCT06584552** · PHASE2 · RECRUITING · sponsor: **The University of New South Wales** · enrollment: 100 (estimated)

## Conditions studied

- Eczema
- Allergy

## Interventions

- **DIETARY_SUPPLEMENT:** Lactobacillus Paracasei LPB27
- **OTHER:** Maltodextrin

## Key facts

- **NCT ID:** NCT06584552
- **Lead sponsor:** The University of New South Wales
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2026-03
- **Final completion:** 2026-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584552, "LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06584552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*